October 7, 2008 - The AccuBoost procedure for treatment of breast cancer is a new image-guided radiation therapy technique for concentrating the radiation dose to the portion of the breast containing the highest concentration of cancer cells.
The AccuBoost has recently been cleared by the FDA for use in women with early stage breast cancer. The Center for Radiation Oncology (CRO), a group of oncology clinics in Florida, is reportedly the first in the state to receive and use AccuBoost.
AccuBoost is a noninvasive imaging and radiation delivery system that focuses radiation from Iridium-192 sources into the portion of the woman’s breast that harbored her tumor. The size and location of the radiation beam is determined by a radiation oncologist using real-time mammography to pinpoint the tissue that needs to be irradiated.
Kathryn Kepes, M.D., a board-certified medical oncologist and radiation oncologist at the Center for Radiation Oncology said “the AccuBoost design delivers a conformal dose to the target tissue, sparing the remainder of the breast and underlying lung and heart from adverse radiation effects.”